SCHEMBL5651922

SCHEMBL5651922

COc1cc(N)c(OC)c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.57
EP300 Q09472 2/20 0.55
KAT8 Q9H7Z6 1/20 0.55
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPK1 P28482 1/20 0.54
TDP1 Q9NUW8 2/20 0.48
ADRA2B P18089 1/20 0.48
PTGS1 P23219 1/20 0.48
NSD2 O96028 1/20 0.42
CASP6 P55212 1/20 0.42
G6PD P11413 1/20 0.42
TSHR P16473 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30503944 0.81 SMN1; SMN2 (0.61) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL3670609 0.81 SMN1; SMN2 (0.61) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL17787244 0.78 IDO1 (0.55) IDO1EP300KAT8ALDH1A1KDM4E
SCHEMBL29741516 0.78 KDM4E (0.56) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL3760438 0.78 KDM4E (0.56) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL21830347 0.76 ALDH1A1 (0.54) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL30678878 0.76 SMN1; SMN2 (0.54) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL17765084 0.76 EP300 (0.55) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL3734274 0.76 SMN1; SMN2 (0.54) IDO1EP300KAT8ALDH1A1SMN1; SMN2
SCHEMBL3747262 0.76 SMN1; SMN2 (0.54) IDO1EP300KAT8ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 IDO1 1321/4885EP300 3216/4885KAT8 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.